FILSPARI 400 mg/1
sparsentan · TABLET, FILM COATED · Travere Therapeutics, Inc.
No Recall History
Plain English
FILSPARI is a tablet, film coated containing sparsentan at 400 mg/1, taken oral. Manufactured by Travere Therapeutics, Inc..
Key Facts
- Brand Name
- FILSPARI
- Generic Name
- sparsentan
- NDC Code (Product)
68974-400- Manufacturer
- Travere Therapeutics, Inc.
- Strength
- 400 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA216403
- Drug Class
- Endothelin Receptor Antagonist [EPC]; Angiotensin 2 Receptor Blocker [EPC]
- Marketing Start
- 02/17/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is FILSPARI used for?
FILSPARI contains sparsentan. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is FILSPARI a controlled substance?
FILSPARI is not classified as a controlled substance by the DEA.
What is the generic name for FILSPARI?
The generic name for FILSPARI is sparsentan. There are no other listed brand versions of sparsentan.
What is the NDC code for FILSPARI 400 mg/1?
The NDC (National Drug Code) for FILSPARI 400 mg/1 is 68974-400, listed by Travere Therapeutics, Inc..
Other FILSPARI Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)